---
title: CROs offering ICH Stability Studies with Biologics (Monoclonal Antibodies)
path: /explore/stability-studies/biologics-monoclonal-antibodies
companies_count: 14
---

# CROs offering ICH Stability Studies with Biologics (Monoclonal Antibodies)

14 published CROs match ICH Stability Studies and Biologics (Monoclonal Antibodies).

Locations in this set include United States, China, Australia, India, Netherlands, and South Korea.

Capabilities that show up most often in this set: Analytical Method Development & Validation, Bioanalysis, Immunogenicity Assays (ADA / NAb), Biomarker Assays, and Flow Cytometry Services.

## Matching companies

- [Allucent](/companies/allucent)
  - Allucent is a full-service CRO specializing in clinical development solutions for small and mid-sized biotech companies.
- [Aragen Life Sciences](/companies/aragen)
  - Global CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.
- [BioAgilytix](/companies/bioagilytix)
  - Bioanalytical CRO specializing in pharmacokinetics, immunogenicity, biomarkers, and CMC analytics with 30+ years of experience and 1,100+ employees conducting 5M+ tests annually.
- [BioDuro-Sundia](/companies/bioduro-sundia)
  - BioDuro-Sundia is a contract research, development, and manufacturing organization (CRDMO) with 30 years of expertise providing integrated drug discovery, development, and manufacturing services from target identification through IND submission.
- [ChemPartner](/companies/chempartner)
  - Global preclinical CRO with 20+ years of experience supporting drug discovery through IND submission across small molecules and biologics, with 2,000+ scientists and facilities worldwide.
- [Frontage Laboratories](/companies/frontagelab)
  - Global pharmaceutical development organization offering integrated drug discovery, preclinical safety/toxicology, DMPK, bioanalytical, and clinical trial services across 28 sites with 2,200 employees and 200+ FDA inspections.
- [NorthEast BioLab](/companies/nebiolab)
  - Bioanalytical CRO providing PK/PD, immunogenicity (ADA/nAb), cytokine, and biomarker assays across LC-MS, Meso Scale Discovery, ELISA, and ddPCR platforms. Operates GLP/GCLP-compliant facilities and reports DEA and CT approval for Schedule I–IV bioanalysis.
- [Pharmaron](/companies/pharmaron)
  - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- [ProBio](/companies/probio)
  - ProBio is a leading global CDMO subsidiary of GenScript Biotech Corporation, providing end-to-end services for biologics and cell & gene therapy (CGT) from drug discovery through commercialization.
- [Sannova](/companies/sannova)
  - Sannova provides bioanalytical and analytical CRO services, including immunogenicity and ligand binding assays, PK testing, DMPK services, extractables and leachables, nitrosamine testing, and pharmaceutical stability testing. Its listed work spans small molecules, biologics and biosimilars, and cell and gene therapies.
- [Selvita](/companies/selvita)
  - Selvita is an integrated drug discovery and development service provider offering comprehensive solutions from target validation through preclinical candidate nomination and clinical manufacturing, with expertise in small molecules, antibodies, and protein degraders.
- [Solvias](/companies/solvias)
  - Global cGMP contract research organization providing comprehensive analytical services for drug development, from preclinical through commercialization, with expertise in biologics, cell & gene therapies, and small molecules.
- [Syngene International](/companies/syngeneintl)
  - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
- [WuXi AppTec](/companies/wuxiapptec)
  - Global CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.